A Study on the Withdrawal of Second-generation Tyrosine Kinase Inhibitors After Dose Reduction in Patients With CML

Clinical trial NCT05341050 · UNKNOWN

Trial details

NCT number: NCT05341050
Sponsor: xuna
Status: UNKNOWN
Study type: OBSERVATIONAL

MMR on 12 Month

Start date: 2022-04-01
Primary completion: 2025-12-31
Enrollment: 260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.